Lifecore Biomedical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 18, 2026	Dec '25 Dec 31, 2025	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022
Market Cap	164	307	249	172	241	291
Market Cap Growth	-39.13%	23.21%	44.86%	-28.66%	-17.35%	-17.04%
Enterprise Value	290.55	478.64	413.65	329.61	371.76	337.96
Last Close Price	4.38	8.18	6.72	5.62	7.94	9.87
PE Ratio	-	-	-5.29	17.03	-2.39	-2.49
Forward PE	-	-	-	25.55	-	-
PEG Ratio	-	20.25	20.25	20.25	20.25	20.25
PS Ratio	1.27	-	1.93	1.34	2.33	2.62
PB Ratio	4.82	-21.59	186.24	15.18	-56.92	3.32
P/TBV Ratio	-5.62	-21.59	175.14	18.21	-56.23	3.31
P/FCF Ratio	26.37	-	-18.27	-9.47	-6.19	-5.54
P/OCF Ratio	13.07	-	-1207.85	668.34	-13.80	-12.89
EV/Sales Ratio	2.24	-	3.21	2.57	3.60	3.04
EV/EBITDA Ratio	35.25	-	-44.87	-370.35	-43.13	53.90
EV/EBIT Ratio	-	-	-23.99	-37.27	-17.06	-28.66
EV/FCF Ratio	46.64	-	-30.37	-18.17	-9.55	-6.43
Debt / Equity Ratio	-5.20	-9.95	95.06	10.93	-26.19	0.54
Debt / EBITDA Ratio	-74.30	-	-13.78	-139.02	-13.07	23.96
Debt / FCF Ratio	-24.73	-	-9.32	-6.82	-2.89	-2.86
Net Debt / Equity Ratio	-4.46	-8.72	88.87	10.19	-22.11	1.70
Net Debt / EBITDA Ratio	-63.84	-	-12.88	-129.51	-10.85	23.80
Net Debt / FCF Ratio	-21.25	-	-8.72	-6.35	-2.40	-2.84
Asset Turnover	0.56	0	0.52	0.51	0.39	0.29
Inventory Turnover	3.07	0	2.45	2.14	1.96	1.46
Quick Ratio	2.33	2.18	1.72	1.02	1.22	0.22
Current Ratio	3.79	3.49	2.84	2.08	2.39	0.66
Return on Equity (ROE)	175.33%	0.00%	-612.08%	263.40%	-153.69%	-10.65%
Return on Assets (ROA)	-4.50%	0.00%	-6.98%	-3.55%	-8.21%	-3.80%
Return on Invested Capital (ROIC)	-5.49%	0.00%	-8.45%	-4.42%	-9.72%	-4.11%
Return on Capital Employed (ROCE)	-5.00%	0.00%	-8.13%	-4.12%	-13.95%	-4.72%
Earnings Yield	-21.00%	0.00%	-18.90%	5.87%	-41.81%	-40.22%
FCF Yield	3.79%	0.00%	-5.47%	-10.56%	-16.17%	-18.03%
Buyback Yield / Dilution	-1.63%	-7.64%	5.02%	-22.37%	-1.67%	-0.59%
Total Shareholder Return	-1.63%	-7.64%	5.02%	-22.37%	-1.67%	-0.59%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q